Case Studies in Diabetes: Escalating treatment with combination dulaglutide and insulin

AUS

$0

free

RACGP CPD Program

30 min

Endocrinology

1 Credits

This course is expired! Browse All Courses
LEARN MORE

Course Description

This latest panel discussion reviews new opportunities in the management of type-2 diabetes brought about by recent changes to the RACGP/ADS guidelines and new PBS reimbursement criteria, particularly with regard to combination therapies.

The video is framed around 2 case studies, which are discussed by the panellists.

This program is supported by an independent educational grant provided from Eli Lilly.

Course Details

Expiry Date: 2022-08-09

Professions: Physician

Faculty

Dr Anita Sharma, General Practitioner, Queensland. 

Dr Ted Wu, Director of the Diabetes Centre, Royal Prince Alfred Hospital.  

Prof Richard MacIsaac, Professor and Director of Endocrinology & Diabetes, St Vincent’s Health.

Accreditation

Members are able to claim CPD activity points for 1 points through ‘Quick log’ on their RACGP CPD Dashboard.

Learning Objective(s)

This panel discussion is designed to enable participants to be better able to:

  • Recognise the new PBS reimbursement criteria for use of GLP1-RAs in combination with insulin 
  • Identify ideal patient profiles for concomitant use of insulin with respect to achieving glycaemic control and CV benefit 
  • Discuss the clinical benefits of concomitant use of GLP1-RAs and insulin with patients 
This course is expired! Browse All Courses